These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 31839777)

  • 1. How frequently does palmoplantar psoriasis affect the palms and/or soles? A systematic review and meta-analysis.
    Timotijević ZS; Trajković G; Jankovic J; Relić M; Đorić D; Vukićević D; Relić G; Rašić D; Filipović M; Janković S
    Postepy Dermatol Alergol; 2019 Oct; 36(5):595-603. PubMed ID: 31839777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pustular Psoriasis: A Narrative Review of Recent Developments in Pathophysiology and Therapeutic Options.
    Menter A; Van Voorhees AS; Hsu S
    Dermatol Ther (Heidelb); 2021 Dec; 11(6):1917-1929. PubMed ID: 34626330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics and prevalence of plaque psoriasis in patients with palmoplantar pustulosis.
    Andersen YMF; Augustin M; Petersen J; Hagenström K; Mallbris L; Burge R; Egeberg A
    Br J Dermatol; 2019 Nov; 181(5):976-982. PubMed ID: 30815849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Efficacy of Biologic Therapy for the Management of Palmoplantar Psoriasis and Palmoplantar Pustulosis: A Systematic Review.
    Sanchez IM; Sorenson E; Levin E; Liao W
    Dermatol Ther (Heidelb); 2017 Dec; 7(4):425-446. PubMed ID: 29143230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Palmoplantar Dermatoses- A Clinical Study of 300 Cases.
    Hongal AA; Rajashekhar N; Gejje S
    J Clin Diagn Res; 2016 Aug; 10(8):WC04-7. PubMed ID: 27656539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extra-palmoplantar lesions associated with palmoplantar pustulosis.
    Yamamoto T
    J Eur Acad Dermatol Venereol; 2009 Nov; 23(11):1227-32. PubMed ID: 19453807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased expression of IL-17A and limited involvement of IL-23 in patients with palmo-plantar (PP) pustular psoriasis or PP pustulosis; results from a randomised controlled trial.
    Bissonnette R; Nigen S; Langley RG; Lynde CW; Tan J; Fuentes-Duculan J; Krueger JG
    J Eur Acad Dermatol Venereol; 2014 Oct; 28(10):1298-305. PubMed ID: 24112799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Palmoplantar pustulosis: Current understanding of disease definition and pathomechanism.
    Murakami M; Terui T
    J Dermatol Sci; 2020 Apr; 98(1):13-19. PubMed ID: 32201085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biologic therapies associated with development of palmoplantar pustulosis and palmoplantar pustular psoriasis: a systematic review.
    Lu JD; Lytvyn Y; Mufti A; Zaaroura H; Sachdeva M; Kwan S; Abduelmula A; Kim P; Yeung J
    Int J Dermatol; 2023 Jan; 62(1):12-21. PubMed ID: 35128653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A brief guide to pustular psoriasis for primary care providers.
    Crowley JJ; Pariser DM; Yamauchi PS
    Postgrad Med; 2021 Apr; 133(3):330-344. PubMed ID: 33118424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Palmoplantar lesions in psoriasis: a study of 3065 patients.
    Kumar B; Saraswat A; Kaur I
    Acta Derm Venereol; 2002; 82(3):192-5. PubMed ID: 12353710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What do we know about palmoplantar pustulosis?
    Misiak-Galazka M; Wolska H; Rudnicka L
    J Eur Acad Dermatol Venereol; 2017 Jan; 31(1):38-44. PubMed ID: 27521275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in palmoplantar pustulosis.
    Brunasso AMG; Massone C
    Fac Rev; 2021; 10():62. PubMed ID: 34409425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Epidemiology of Palmoplantar Pustulosis: An Analysis of Multiple Health Insurance Claims and Electronic Health Records Databases.
    Ramcharran D; Strober B; Gordon K; DeKlotz C; Fakharzadeh S; Yang YW; Swerdel J; Hardin J; Dronavalli S; Paller AS
    Adv Ther; 2023 Nov; 40(11):5090-5101. PubMed ID: 37737889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triggering role of focal infection in the induction of extra-palmoplantar lesions and pustulotic arthro-osteitis associated with palmoplantar pustulosis.
    Yamamoto T
    Adv Otorhinolaryngol; 2011; 72():89-92. PubMed ID: 21865699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and epidemiological comparison of patients affected by palmoplantar plaque psoriasis and palmoplantar pustulosis: a case series study.
    Brunasso AM; Puntoni M; Aberer W; Delfino C; Fancelli L; Massone C
    Br J Dermatol; 2013 Jun; 168(6):1243-51. PubMed ID: 23301847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Characteristics of Japanese Patients with Palmoplantar Pustulosis.
    Yamamoto T
    Clin Drug Investig; 2019 Mar; 39(3):241-252. PubMed ID: 30632109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Refractory Palmoplantar Pustulosis Successfully Treated with JAK Inhibitor Tofacitinib: A Case Series.
    Xu Q; Wang X; Yang A; Wei G
    Infect Drug Resist; 2023; 16():5165-5172. PubMed ID: 37581169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical 0.25% methotrexate gel in a hydrogel base for palmoplantar psoriasis.
    Kumar B; Sandhu K; Kaur I
    J Dermatol; 2004 Oct; 31(10):798-801. PubMed ID: 15672706
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.